In summary, hyperlipidemia accelerates thromboinflammation in vitro and in vivo via ACSL1‐dependent monocyte activation, further demonstrating that NETosis is accelerated in hyperlipidemic states, which consequently aggravates the thromboinflammatory process in mIRI. This evidence concerns the gene ACSL1 and hyperlipidemia.